AR081765A1 - Composiciones farmaceuticas topicas - Google Patents
Composiciones farmaceuticas topicasInfo
- Publication number
- AR081765A1 AR081765A1 ARP110101784A ARP110101784A AR081765A1 AR 081765 A1 AR081765 A1 AR 081765A1 AR P110101784 A ARP110101784 A AR P110101784A AR P110101784 A ARP110101784 A AR P110101784A AR 081765 A1 AR081765 A1 AR 081765A1
- Authority
- AR
- Argentina
- Prior art keywords
- weight
- pharmaceutical compositions
- skin
- compositions
- topic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones farmacéuticas tópicas que comprenden, en base al peso total de la composición: a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua, y d) 25 a 70% en peso de una fase oleosa. Dichas composiciones son estables y se pueden aplicar de modo sencillo y seguro a grandes superficies de piel de modo aceptable por los pacientes en general, para el tratamiento o la prevención de psoriasis, dermatitis atópica (eczema atópico) y otros trastornos o enfermedades de la piel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10382146A EP2394653A1 (en) | 2010-05-26 | 2010-05-26 | Topical pharmaceutical compositions comprising mometasone furoate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR081765A1 true AR081765A1 (es) | 2012-10-17 |
Family
ID=42797321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101784A AR081765A1 (es) | 2010-05-26 | 2011-05-24 | Composiciones farmaceuticas topicas |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20140200203A1 (es) |
| EP (2) | EP2394653A1 (es) |
| JP (1) | JP5743241B2 (es) |
| KR (1) | KR101790371B1 (es) |
| CN (1) | CN102883725B (es) |
| AR (1) | AR081765A1 (es) |
| AU (1) | AU2011257586B2 (es) |
| BR (1) | BR112012030006A2 (es) |
| CA (1) | CA2794553C (es) |
| CL (1) | CL2012003282A1 (es) |
| CO (1) | CO6640244A2 (es) |
| DK (1) | DK2575822T3 (es) |
| EA (1) | EA022967B1 (es) |
| ES (1) | ES2595250T3 (es) |
| HK (1) | HK1177893A1 (es) |
| HR (1) | HRP20161288T1 (es) |
| HU (1) | HUE029818T2 (es) |
| IL (1) | IL222163B (es) |
| LT (1) | LT2575822T (es) |
| ME (1) | ME02555B (es) |
| MX (1) | MX2012013642A (es) |
| MY (1) | MY160377A (es) |
| NZ (1) | NZ602730A (es) |
| PL (1) | PL2575822T3 (es) |
| PT (1) | PT2575822T (es) |
| RS (1) | RS55233B1 (es) |
| SG (2) | SG10201502252YA (es) |
| SI (1) | SI2575822T1 (es) |
| SM (1) | SMT201600342B (es) |
| TW (1) | TWI473615B (es) |
| UY (1) | UY33404A (es) |
| WO (1) | WO2011147536A2 (es) |
| ZA (1) | ZA201208420B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2394653A1 (en) | 2010-05-26 | 2011-12-14 | Almirall, S.A. | Topical pharmaceutical compositions comprising mometasone furoate |
| US11135297B2 (en) * | 2013-07-11 | 2021-10-05 | Pola Pharma Inc. | External-use composition producing foamed state upon use |
| GB2540764A (en) * | 2015-07-24 | 2017-02-01 | Fontus Health Ltd | Topical composition |
| CA3061238A1 (en) * | 2017-03-10 | 2018-09-13 | Rutgers, The State University Of New Jersey | Indole derivatives as efflux pump inhibitors |
| EP3492068A1 (en) * | 2017-12-01 | 2019-06-05 | NCP NewCare Products GmbH | Composition for treating onychomycosis |
| CN114767630A (zh) * | 2022-06-06 | 2022-07-22 | 黑龙江中医药大学 | 一种治疗变应性鼻炎的药物组合物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4808610A (en) | 1986-10-02 | 1989-02-28 | Schering Corporation | Mometasone furoate anti-inflammatory cream composition using hexylene glycol |
| US4775529A (en) | 1987-05-21 | 1988-10-04 | Schering Corporation | Steroid lotion |
| US5422361A (en) | 1989-12-20 | 1995-06-06 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| NZ278198A (en) | 1993-12-21 | 1997-12-19 | Schering Corp | Pharmaceutical compositions comprising mometasone furoate and salicyclic acid; use in treatment of psoriasis |
| US5696105A (en) * | 1996-03-14 | 1997-12-09 | Hackler; Walter A. | Antifungal nail composition |
| CA2305256C (en) | 1997-10-09 | 2005-05-17 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| TR200201343A2 (tr) | 2002-05-17 | 2003-12-22 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve antiseptik içeren farmasötik bileşim |
| CA2532707A1 (en) | 2003-05-23 | 2004-12-09 | Taro Pharmaceuticals U.S.A., Inc. | Novel topical steroid cream formulations |
| DE102006034883A1 (de) | 2006-07-25 | 2008-01-31 | Hermal Kurt Herrmann Gmbh & Co. Ohg | Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat |
| EP2120868A4 (en) | 2007-04-11 | 2010-08-25 | Perrigo Israel Phamaceuticals | LOW-DOSED MOMETASON FORMULATIONS |
| EP2394653A1 (en) | 2010-05-26 | 2011-12-14 | Almirall, S.A. | Topical pharmaceutical compositions comprising mometasone furoate |
-
2010
- 2010-05-26 EP EP10382146A patent/EP2394653A1/en not_active Withdrawn
-
2011
- 2011-05-13 AU AU2011257586A patent/AU2011257586B2/en not_active Ceased
- 2011-05-13 RS RS20160837A patent/RS55233B1/sr unknown
- 2011-05-13 WO PCT/EP2011/002369 patent/WO2011147536A2/en active Application Filing
- 2011-05-13 PT PT117194878T patent/PT2575822T/pt unknown
- 2011-05-13 PL PL11719487T patent/PL2575822T3/pl unknown
- 2011-05-13 SG SG10201502252YA patent/SG10201502252YA/en unknown
- 2011-05-13 EA EA201291335A patent/EA022967B1/ru not_active IP Right Cessation
- 2011-05-13 BR BR112012030006A patent/BR112012030006A2/pt not_active Application Discontinuation
- 2011-05-13 EP EP11719487.8A patent/EP2575822B1/en active Active
- 2011-05-13 CA CA2794553A patent/CA2794553C/en not_active Expired - Fee Related
- 2011-05-13 ME MEP-2016-187A patent/ME02555B/me unknown
- 2011-05-13 ES ES11719487.8T patent/ES2595250T3/es active Active
- 2011-05-13 JP JP2013511568A patent/JP5743241B2/ja not_active Expired - Fee Related
- 2011-05-13 MX MX2012013642A patent/MX2012013642A/es active IP Right Grant
- 2011-05-13 NZ NZ602730A patent/NZ602730A/en not_active IP Right Cessation
- 2011-05-13 DK DK11719487.8T patent/DK2575822T3/en active
- 2011-05-13 CN CN201180023073.7A patent/CN102883725B/zh active Active
- 2011-05-13 KR KR1020127029977A patent/KR101790371B1/ko active IP Right Grant
- 2011-05-13 HU HUE11719487A patent/HUE029818T2/en unknown
- 2011-05-13 US US13/699,333 patent/US20140200203A1/en not_active Abandoned
- 2011-05-13 LT LTEP11719487.8T patent/LT2575822T/lt unknown
- 2011-05-13 MY MYPI2012004874A patent/MY160377A/en unknown
- 2011-05-13 SI SI201130986A patent/SI2575822T1/sl unknown
- 2011-05-13 SG SG2012073235A patent/SG184405A1/en unknown
- 2011-05-24 UY UY0001033404A patent/UY33404A/es not_active Application Discontinuation
- 2011-05-24 AR ARP110101784A patent/AR081765A1/es unknown
- 2011-05-24 TW TW100118106A patent/TWI473615B/zh not_active IP Right Cessation
-
2012
- 2012-09-27 IL IL222163A patent/IL222163B/en active IP Right Grant
- 2012-11-08 ZA ZA2012/08420A patent/ZA201208420B/en unknown
- 2012-11-23 CL CL2012003282A patent/CL2012003282A1/es unknown
- 2012-11-23 CO CO12212409A patent/CO6640244A2/es not_active Application Discontinuation
-
2013
- 2013-05-13 HK HK13105652.3A patent/HK1177893A1/zh not_active IP Right Cessation
-
2015
- 2015-10-15 US US14/883,898 patent/US9907807B2/en active Active
-
2016
- 2016-09-29 SM SM201600342T patent/SMT201600342B/it unknown
- 2016-10-06 HR HRP20161288TT patent/HRP20161288T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6640244A2 (es) | Composiciones farmacéuticas tópicas | |
| BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
| CR20130524A (es) | Derivados de ácido 3-fenilpropiónico ramificados y su uso | |
| WO2014188276A3 (en) | Antioxidant compositions and methods of using the same | |
| DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
| EA201291108A1 (ru) | Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген | |
| AR084932A1 (es) | Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica | |
| BR112013025878A2 (pt) | composição farmacêutica e método para produzir uma composição farmacêutica | |
| CL2016000544A1 (es) | Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel. | |
| CO2019007409A2 (es) | Derivados de la pirimidin enona tricíclica para la inhibición de rorγ y otros usos | |
| AR091039A1 (es) | Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento | |
| CO6710926A2 (es) | Compuestos de n-heteroarilo | |
| BR112012017554B8 (pt) | formulações de anestésicas locais formadoras de sólido para controle da dor | |
| BR112015030315A2 (pt) | derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo | |
| PE20150353A1 (es) | Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos | |
| BR112014020271A8 (pt) | Composição farmacêutica e métodos para diminuir a frequência de micção em paciente | |
| BR112016000092A2 (pt) | nanopartículas lipídicas para a cicatrização de feridas | |
| BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
| BR112015027436A8 (pt) | composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos | |
| AR084197A1 (es) | Composicion para uso topico para el tratamiento de trastornos de la piel | |
| BR112015014367A2 (pt) | formulações inibidoras de lfa-1 | |
| BR112014030288A2 (pt) | composição farmacêutica | |
| BR112013026564A2 (pt) | uso de uma combinação | |
| MX2016008546A (es) | Reduccion de queloides utilizando alantoina topica. | |
| NI201200196A (es) | Agentes terapéuticos 976 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |